FBIOP
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock$17.25-0.54 (-3.04%)Prev Close$17.79·MCap$107.6M·P/E—·Vol5.2K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
FBIOP Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | Fortress Biotech, Inc. | Sell | 100,000 | $1.29 | $129.0K1.3% OS | 6,122,249 | |
| Sep 25, 2024 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Buy | 1,526,718 | $0.98 | $1.50M20.2% OS | 3,657,264+72% |
| Jul 1, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 20,000 | $1.64 | $32.7K | 2,893,905 |
| May 20, 2024 | Klein Dov | Director | Sell | 10,000 | $1.89 | $18.9K | 53,400 |
| May 20, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 10,000 | $1.76 | $17.6K | 2,873,905 |
| Jan 9, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 50,000 | $2.38 | $118.8K0.7% OS | 2,863,905 |
| Nov 16, 2023 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 1,567,515 | $1.70 | $2.66M20.7% OS | 2,597,440+152% |
| Nov 16, 2023 | WEISS MICHAEL S | See Remarks | Buy | 147,058 | $1.70 | $250.0K1.9% OS | 1,130,520 |
| Sep 27, 2023 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 100,000 | $0.28 | $28.3K1.3% OS | 15,449,091 |
| Sep 12, 2023 | Fortress Biotech, Inc. | 10% Owner | Buy | 418,410 | $0.72 | $301.3K5.5% OS | 1,032,390+68% |
| Feb 14, 2023 | Jin David | Chief Financial Officer | Buy | 35,928 | $0.84 | $30.0K | 1,438,757 |
| Feb 14, 2023 | LOBELL J JAY | Director | Buy | 299,401 | $0.84 | $250.0K4.0% OS | 1,635,401 |
| Feb 14, 2023 | Lu Lucy | Director | Buy | 11,976 | $0.84 | $10.0K | 133,379 |
| Feb 14, 2023 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 2,395,209 | $0.84 | $2.00M31.7% OS | 15,349,091 |
| Feb 14, 2023 | Rowinsky Eric K | Director | Buy | 11,976 | $0.84 | $10.0K | 931,976 |
| Feb 14, 2023 | WEISS MICHAEL S | See Remarks | Buy | 1,197,604 | $0.83 | $1000.0K15.8% OS | 14,752,034 |
| Dec 5, 2022 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Buy | 100,000 | $0.68 | $68.0K1.3% OS | 11,730,324 |
| Dec 2, 2022 | Jin David | Chief Financial Officer | Buy | 5,000 | $0.56 | $2.8K | 1,402,829 |
| Dec 2, 2022 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Buy | 5,000 | $0.56 | $2.8K | 11,630,324 |
| Oct 24, 2022 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Buy | 100,000 | $0.70 | $69.5K1.3% OS | 11,625,324 |
| Apr 29, 2022 | Hunter Robyn | Chief Financial Officer | Sell | 28,292 | $3.13 | $88.6K | 163,877 |
| Apr 29, 2022 | Klein Dov | Director | Sell | 5,000 | $2.45 | $12.3K | 651,015 |
| Apr 9, 2021 | Rowinsky Eric K | Director | Sell | 10,000 | $4.45 | $44.5K | 720,000 |
FBIOP Insider Buying Activity
The following table shows recent insider purchases of Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Buy | 1,526,718 | $0.98 | $1.50M20.2% OS | 3,657,264+72% |
| Jul 1, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 20,000 | $1.64 | $32.7K | 2,893,905 |
| May 20, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 10,000 | $1.76 | $17.6K | 2,873,905 |
| Jan 9, 2024 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 50,000 | $2.38 | $118.8K0.7% OS | 2,863,905 |
| Nov 16, 2023 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 1,567,515 | $1.70 | $2.66M20.7% OS | 2,597,440+152% |
| Nov 16, 2023 | WEISS MICHAEL S | See Remarks | Buy | 147,058 | $1.70 | $250.0K1.9% OS | 1,130,520 |
| Sep 27, 2023 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 100,000 | $0.28 | $28.3K1.3% OS | 15,449,091 |
| Sep 12, 2023 | Fortress Biotech, Inc. | 10% Owner | Buy | 418,410 | $0.72 | $301.3K5.5% OS | 1,032,390+68% |
| Feb 14, 2023 | Jin David | Chief Financial Officer | Buy | 35,928 | $0.84 | $30.0K | 1,438,757 |
| Feb 14, 2023 | LOBELL J JAY | Director | Buy | 299,401 | $0.84 | $250.0K4.0% OS | 1,635,401 |
| Feb 14, 2023 | Lu Lucy | Director | Buy | 11,976 | $0.84 | $10.0K | 133,379 |
| Feb 14, 2023 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Buy | 2,395,209 | $0.84 | $2.00M31.7% OS | 15,349,091 |
| Feb 14, 2023 | Rowinsky Eric K | Director | Buy | 11,976 | $0.84 | $10.0K | 931,976 |
| Feb 14, 2023 | WEISS MICHAEL S | See Remarks | Buy | 1,197,604 | $0.83 | $1000.0K15.8% OS | 14,752,034 |
| Dec 5, 2022 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Buy | 100,000 | $0.68 | $68.0K1.3% OS | 11,730,324 |
| Dec 2, 2022 | Jin David | Chief Financial Officer | Buy | 5,000 | $0.56 | $2.8K | 1,402,829 |
| Dec 2, 2022 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Buy | 5,000 | $0.56 | $2.8K | 11,630,324 |
| Oct 24, 2022 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Buy | 100,000 | $0.70 | $69.5K1.3% OS | 11,625,324 |
FBIOP Insider Selling Activity
The following table shows recent insider sales of Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | Fortress Biotech, Inc. | Sell | 100,000 | $1.29 | $129.0K1.3% OS | 6,122,249 | |
| May 20, 2024 | Klein Dov | Director | Sell | 10,000 | $1.89 | $18.9K | 53,400 |
| Apr 29, 2022 | Hunter Robyn | Chief Financial Officer | Sell | 28,292 | $3.13 | $88.6K | 163,877 |
| Apr 29, 2022 | Klein Dov | Director | Sell | 5,000 | $2.45 | $12.3K | 651,015 |
| Apr 9, 2021 | Rowinsky Eric K | Director | Sell | 10,000 | $4.45 | $44.5K | 720,000 |
FBIOP Insiders
Similar Stocks to FBIOP
AGNCZ
AGNC Investment Corp. 8.75% Series H Fixed-Rate Cumulative Redeemable Preferred Stock
$25.37+0.39%
$28.00B
AGNCP
AGNC Investment Corp. Depositary Shares Each Representing a 1/1,000th Interest in a Share of 6.125% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
$25.37+0.04%
$9.83B
USO
United States Oil Fund, LP
$147.91-3.80%
$9.58B
KYN
Kayne Anderson Energy Infrastructure Fund, Inc.
$14.40-0.21%
$2.33B
CLM
Cornerstone Strategic Investment Fund, Inc.
$6.36+0.95%
$2.24B
BCAT
BlackRock Capital Allocation Term Trust
$14.18-1.15%
$1.57B
CET
Central Securities Corp.
$56.42+1.61%
$1.51B
ECAT
BlackRock ESG Capital Allocation Term Trust
$14.45+0.63%
$1.50B